|
WO2020051317A1
|
|
Oral film compositions and dosage forms having precise active dissolution profiles
|
|
US2019328679A1
|
|
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
AU2019288476A1
|
|
System and method for making personalized individual unit doses containing pharmaceutical actives
|
|
US2019046411A1
|
|
Sublingual and buccal film compositions
|
|
CN111132670A
|
|
Pharmaceutical composition with enhanced penetration
|
|
US2019022023A1
|
|
Enhanced delivery epinephrine and prodrug compositions
|
|
US2019022022A1
|
|
Pharmaceutical compositions with enhanced permeation
|
|
KR20200060748A
|
|
Enhanced delivery ephnephrine and prodrug compositions
|
|
CN111148512A
|
|
Delivery pharmaceutical composition comprising a penetration enhancer
|
|
EP3452023A1
|
|
Enhanced delivery epinephrine compositions
|
|
CN109310647A
|
|
Pharmaceutical composition with enhancing infiltration
|
|
EP2533769A1
|
|
Method and system for optimizing film production and minimizing film scrap
|
|
AU2002332118B2
|
|
Glucan based film delivery systems
|
